-+ 0.00%
-+ 0.00%
-+ 0.00%

ZENTALIS PHARMACEUTICALS ANNOUNCES MEANINGFUL MEDIAN OVERALL SURVIVAL DATA IN CYCLIN E1-POSITIVE PLATINUM-RESISTANT OVARIAN CANCER FROM DENALI PART 1B TO BE PRESENTED AT THE ESMO CONGRESS 2026

Reuters·10/23/2026 14:15:00

Please log in to view news